Adam Colborn, JD, associate vice president of Congressional Affairs, AMCP
Potential Impacts of Halting the CGT Access Model: AMCP's Adam Colborn
Abandoning efforts to reform payment for cell and gene therapies for Medicaid beneficiaries could allow ongoing access barriers to persist, said Adam Colborn, JD, of AMCP.
AMCP's Adam Colborn on the Real-World Impacts of Drug Pricing Legislation
Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to reduce prices and increase access.
How Trump's Initial Executive Orders May Impact Medicaid, Medicare Models
Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact Medicaid and Medicare initiatives.
How Climate-Driven Disasters Could Reshape Health Care Quality Measures
Enhancing Diversity, Addressing Racial Disparities in Psoriatic Arthritis Research
Camden Coalition’s Complex Care Education Extends to Various Sectors
Bimekizumab, Brodalumab Safe, Effective Up to 36 Weeks for Psoriasis